| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC2333 | His-tagged PCSK9 | IgG1 kappa | ELISA; Block | ||
| V3S-0522-YC2505 | IgG4 kappa | ELISA; Inhib | 8.749 pM | ||
| V3S-0522-YC7528 | Human proprotein convertase subtilisin/kexin type 9 | IgG | WB; Block; FuncS | ||
| V3S-0522-YC8296 | Human proprotein convertase subtilisin/kexin type 9 | IgG2 | ELISA; WB; Neut | ||
| V3S-0622-YC2341 | IgG2 kappa | FuncS | |||
| V3S-0622-YC421 | IgG1 lambda | Antagonist; ELISA; FuncS | 2.05 nM | ||
| V3S-0622-YC5177 | IgG | FuncS | |||
| V3S-0622-YC5178 | IgG | WB; FC; IP; ELISA; Neut; FuncS; IF | |||
| V3S-0622-YC5180 | IgG | ELISA; FC; IP; FuncS; IF; Neut; ICC | |||
| V3S-0622-YC5181 | IgG | Neut; ELISA; IF; IP; FuncS; FC; ICC | |||
| V3S-0822-YC2191 | LDLR binding region of human PCSK9 | IgG1 | Neut | ||
| V3S-1022-YC6022 | IgG1 kappa | IP; IF; FuncS; FC; Neut; ELISA; ICC | |||
| V3S-1222-YC1103 | IgG | ELISA; Block | |||
| V3S-0522-YC7215 | IgG | ELISA | |||
| V3S-0522-YC7864 | Human proprotein convertase subtilisinkexin type 9 | IgG | WB; FuncS | ||
| V3S-0522-YC7866 | Human proprotein convertase subtilisinkexin type 9 | IgG | ELISA; WB | ||
| V3S-0622-YC2346 | IgG | ELISA | |||
| V3S-1022-YC213 | IgG | ELISA | |||
| V3S-1022-YC2198 | IgG | ELISA | 8.1 nM | ||
| V3S-1022-YC31 | Human proprotein convertase subtilisin/kexin type 9 (PCSK9) | IgG2 kappa | Inhib; ELISA | 6.3 nM | |
| V3S-1022-YC386 | IgG1 | Inhib | |||
| V3S-1022-YC526 | IgG2 | Inhib | 0.206 nM | ||
| V3S-1022-YC753 | IgG | Inhib | |||
| V3S-1022-YC81 | IgG1 | IA | |||
| V3S-1222-YC1723 | IgG | ELISA; Inhib | |||
| V3S-1222-YC1724 | IgG | ELISA | |||
| V3S-1222-YC2049 | IgG | ELISA |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Proprotein convertase subtilisin/kexin type 9. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Immunogen | His-tagged PCSK9 |
| Isotype | IgG1, κ |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; Block |
| Application Notes | The antibody is recommended for detection of PCSK9 by ELISA, Block assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | PCSK9 |
| Alternative Name | Proprotein Convertase Subtilisin/Kexin Type 9; Subtilisin/Kexin-Like Protease PC9; NARC-1; NARC1; PC9; Convertase Subtilisin/Kexin Type 9 Preproprotein; Hypercholesterolemia, Autosomal Dominant 3; Neural Apoptosis Regulated Convertase 1; Neural Apoptosis-Regulated Convertase 1; |
| Gene ID | 255738 |
| UniProt | Q8NBP7 |
| Research Area | Signal Pathway; Cardiovascular |
